Enemsa Pharma Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $494K

  • Investors
  • 1

Enemsa Pharma General Information

Description

Developer of small-molecule therapeutics designed to treat neurodegenerative diseases. The company develops oral compounds targeting conditions such as amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, and Parkinson's disease, enabling advancement of therapies that support neuronal survival and reduce disease progression.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 53 Rue de la Gaudinière
  • 44300 Nantes
  • France
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 53 Rue de la Gaudinière
  • 44300 Nantes
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enemsa Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 31-Dec-2025 $494K Completed Clinical Trials - Phase 2
To view Enemsa Pharma’s complete valuation and funding history, request access »

Enemsa Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Enemsa Pharma’s complete cap table history, request access »

Enemsa Pharma Patents

Enemsa Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026215248-A1 Novel combinatorial therapies useful for the treatment of neurological diseases Pending 07-Apr-2025

Enemsa Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Remiges Ventures Venture Capital Minority
To view Enemsa Pharma’s complete investors history, request access »

Enemsa Pharma FAQs

  • When was Enemsa Pharma founded?

    Enemsa Pharma was founded in 2025.

  • Where is Enemsa Pharma headquartered?

    Enemsa Pharma is headquartered in Nantes, France.

  • What industry is Enemsa Pharma in?

    Enemsa Pharma’s primary industry is Drug Discovery.

  • Is Enemsa Pharma a private or public company?

    Enemsa Pharma is a Private company.

  • What is the current valuation of Enemsa Pharma?

    The current valuation of Enemsa Pharma is .

  • What is Enemsa Pharma’s current revenue?

    The current revenue for Enemsa Pharma is .

  • How much funding has Enemsa Pharma raised over time?

    Enemsa Pharma has raised $494K.

  • Who are Enemsa Pharma’s investors?

    Remiges Ventures has invested in Enemsa Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process